Correlation of the microculture-kinetic drug-induced apoptosis assay with patient outcomes in initial treatment of adult acute myelocytic leukemia

References

• Cancer Facts & Figures 2010. Atlanta, GA: American Cancer Society; 2010.
   Google Scholar
• Grimwade D, Walker H, Oliver F, . The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998;92:2322–2333.
   PubMed Web of Science ®Google Scholar
• Mrozek K, Heinonen K, de la Chapelle A, . Clinical significance of cytogenetics in acute myeloid leukemia. Semin Oncol 1997;24: 17–31.
   PubMed Web of Science ®Google Scholar
• Mrozek K, Dohner H, Bloomfield CD. Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances. Curr Opin Hematol 2007;14: 106–114.
   PubMed Web of Science ®Google Scholar
• Schlenk RF, Dohner K, Krauter J, . Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008;358:1909–1918.
   PubMed Web of Science ®Google Scholar
• Yates JW, Wallace HJ Jr, Ellison RR, . Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Cancer Chemother Rep 1973;57: 485–488.
   PubMedGoogle Scholar
• Cree IA, Kurbacher CM, Lamont A, . A prospective randomized controlled trial of tumor chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer. Anticancer Drugs 2007;18: 1093–1101.
   PubMed Web of Science ®Google Scholar
• Wu B, Zhu JS, Zhang Y, . Predictive value of MTT assay as an in vitro chemosensitivity testing for gastric cancer: one institution’s experience. World J Gastroenterol 2008;14:3064–3068.
   PubMed Web of Science ®Google Scholar
• Joo WD, Lee JY, Kim JH, . Efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay in patients with epithelial ovarian cancer. J Gynecol Oncol 2009;20: 96–100.
   PubMed Web of Science ®Google Scholar
• Gallion H, Christopherson WA, Coleman RL, . Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay. Int J Gynecol Cancer 2006;16:194–201.
   PubMed Web of Science ®Google Scholar
• Mi Z, Holmes FA, Hellerstedt B, . Feasibility assessment of a chemoresponse assay to predict pathologic response in neoadjuvant chemotherapy for breast cancer patients. Anticancer Res 2008;28: 1733–1740.
   PubMed Web of Science ®Google Scholar
• Staib PST, Wiedemann S, . Prognostic relevance of in vitro drug sensitivity testing in adult AML. In: Buchner T, Hiddemann W, Wormann B, ., editors. Acute leukemia VIII: prognostic factors and treatment strategies. Berlin: Springer-Verlag; 2001.
   Google Scholar
• Larsson R, Fridborg H, Kristensen J, . In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukemia using the fluorometric microculture cytotoxicity assay (FMCA). Br J Cancer 1993;67:969–974.
   PubMed Web of Science ®Google Scholar
• Hwang WS, Chen LM, Huang SH, . Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test. Leuk Res 1993;17:685–688.
   PubMed Web of Science ®Google Scholar
• Sargent JM, Taylor CG. Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukemia. Br J Cancer 1989;60: 206–210.
   PubMed Web of Science ®Google Scholar
• Santini V, Bernabei PA, Silvestro L, . In vitro chemosensitivity testing of leukemic cells: prediction of response to chemotherapy in patients with acute non-lymphocytic leukemia. Hematol Oncol 1989;7:287–293.
   PubMed Web of Science ®Google Scholar
• Norgaard JM, Langkjer ST, Palshof T, . Relation of blast cell survival and proliferation to chemotherapy resistance in AML. Br J Haematol 1996;93:888–897.
   PubMed Web of Science ®Google Scholar
• Klumper E, Pieters R, Kaspers GJ, . In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia. Leukemia 1995;9:1864–1869.
   PubMed Web of Science ®Google Scholar
• Klumper E, Ossenkoppele GJ, Pieters R, . In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukemia. Br J Haematol 1996;93: 903–910.
   PubMed Web of Science ®Google Scholar
• te Boekhorst PA, Lowenberg B, Sonneveld P. Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay. Leukemia 1993;7:1637–1644.
   PubMed Web of Science ®Google Scholar
• Barzi A, Lepri E, Menconi E, . A 4-day chemosensitivity assay in vitro reliably predicts clinical response of patients with acute leukemia. Haematologica 1989;74:449–454.
   PubMed Web of Science ®Google Scholar
• Lihou MG, Smith PJ. Quantitation of chemosensitivity in acute myelocytic leukemia. Br J Cancer 1983;48:559–567.
   PubMed Web of Science ®Google Scholar
• Nara N, Suzuki T, Nagata K, . Relationship between the in vitro sensitivity to cytosine arabinoside of blast progenitors and the outcome of treatment in acute myeloblastic leukemia patients. Br J Haematol 1988;70:187–191.
   PubMed Web of Science ®Google Scholar
• Dow LW, Dahl GV, Kalwinsky DK, . Correlation of drug sensitivity in vitro with clinical responses in childhood acute myeloid leukemia. Blood 1986;68:400–405.
   PubMed Web of Science ®Google Scholar
• Park CH, Wiernik PH, Morrison FS, . Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs. Cancer Res 1983;43:2346–2349.
   PubMed Web of Science ®Google Scholar
• Hannun YA. Apoptosis and the dilemma of cancer chemotherapy. Blood 1997;89:1845–1853.
   PubMed Web of Science ®Google Scholar
• Kamesaki H. Mechanisms involved in chemotherapy-induced apoptosis and their implications in cancer chemotherapy. Int J Hematol 1998;68:29–43.
   PubMed Web of Science ®Google Scholar
• Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994;73:2013–2026.
   PubMed Web of Science ®Google Scholar
• Sachs L, Lotem J. Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 1993;82:15–21.
   PubMed Web of Science ®Google Scholar
• Kravtsov VD. A novel microculture kinetic assay (MiCK assay) for malignant cell growth and chemosensitivity. Eur J Cancer 1994;30A:1564–1570.
   PubMed Web of Science ®Google Scholar
• Kravtsov VD, Fabian I. Automated monitoring of apoptosis in suspension cell cultures. Lab Invest 1996;74:557–570.
   PubMed Web of Science ®Google Scholar
• Kravtsov VD, Daniel TO, Koury MJ. Comparative analysis of different methodological approaches to the in vitro study of drug-induced apoptosis. Am J Pathol 1999;155:1327–1339.
   PubMed Web of Science ®Google Scholar
• Kravtsov VD, Greer JP, Whitlock JA, . Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemia. Blood 1998;92:968–980.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Bennett JM, Kopecky KJ, . Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003;21:4642–4649.
   PubMed Web of Science ®Google Scholar
• Kravtsov VD, Greer JP, Whitlock JA, . Use of the microculture kinetic (MiCK) assay of apoptosis to determine chemosensitivities of leukemia. Blood 1998;92:968–980.
   PubMed Web of Science ®Google Scholar
• Whitworth PW, Presant CA, Rutledge J, . Chemosensitivity (CS) of patient (pt) breast cancer (BrCa) cells in vitro: correlation with prior chemotherapy (CT) and implications for personalized treatment planning. J Clin Oncol 2009;27(Suppl.): Abstract e11563A.
   Google Scholar
• Ballard KS, Homesley HD, Hodson C, . Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implications for endometrial cancer treatment. J Gynecol Oncol 2010;21:45–49.
   PubMed Web of Science ®Google Scholar
• Salom EM, Penalver M, Homesley HD, . Can we increase response rate (RR) and overall survival (OS) by individualizing chemotherapy in ovarian cancer (OC): the role of new chemotherapy (CT) induced apoptosis assay. J Clin Oncol 2010;28(15 Suppl.): Abstract 5112.
   Web of Science ®Google Scholar
• Bosserman LD, Rajurkar SP, Rogers K, . Correlation of drug-induced apoptosis assay results with oncologist treatment decisions and patient response and survival. Cancer 2012 Feb 21. [Epub ahead of print]
   Web of Science ®Google Scholar
• Burstein HJ, Mangu PB, Somerfield MR, . American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays. J Clin Oncol 2011;29:3328–3330.
   PubMed Web of Science ®Google Scholar